Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients ; volume:13 ; number:1 ; day:15 ; month:1 ; year:2015 ; pages:1 ; date:12.2015
Journal of translational medicine ; 13, Heft 1 (15.1.2015), 1, 12.2015
- Creator
-
Vasaturo, Angela
- Contributor
-
Verweij, Dagmar
Heinzerling, Lucie
de Vries, Jolanda
Blokx, Willeke
Figdor, Carl G.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-13-S1-P12
- URN
-
urn:nbn:de:1111-2016041451111
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vasaturo, Angela
- Verweij, Dagmar
- Heinzerling, Lucie
- de Vries, Jolanda
- Blokx, Willeke
- Figdor, Carl G.
- SpringerLink (Online service)
Other Objects (12)
CD1C is associated with breast cancer prognosis and immune infiltrates
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA
Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer
Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients
Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Immunotherapy of malignant melanoma
Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
CD1C is associated with breast cancer prognosis and immune infiltrates
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA
Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer
Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients
Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Immunotherapy of malignant melanoma
Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
CD1C is associated with breast cancer prognosis and immune infiltrates
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA
Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer
Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients
Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Immunotherapy of malignant melanoma
Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer